Utrecht Science Park,
3584 CL, Utrecht.
+31 30 2532489
We collaborate with the world’s leading pharma, biotech and academic organisations to lower the risks and time frames in disease research and preclinical drug discovery.
Euretos provides a unique combination of predictive computational disease models and direct access to our AI-integrated knowledge base of biomolecular databases, literature and patents to evaluate predictions and findings. This empowers scientists to draw their own, evidence-based, conclusions and develop data-driven insights into human disease biology.
Our ready-to-use applications and capabilities enable taking a data-driven approach to:
- Target Discovery – Novel target predictions to improve preclinical pipeline performance in all therapeutic areas
- Indication Selection – Novel disease association predictions to expand indications of existing drugs
- Target Evaluation – Accelerate assessment of target candidates from in-house discovery and in-licensing.
Work with Euretos to:
- Get novel target and indication predictions to develop your in-house and in-licensing pipeline
- Empower your researchers to evaluate which assets to move forward in preclinical testing
- Gain collaborative insights by working with our translational science team
- Lower time frames and risks by leveraging proven experience and ready-to-use applications.